immune checkpoint inhibitor therapy

Patrick DalyNon-Small Cell Lung Cancer | September 21, 2023

JK5G postbiotics may improve gut microbiota, QOL, and appetite in patients with advanced NSCLC on PD-1 inhibitor therapy.

Patrick DalySmall Cell Lung Cancer | September 21, 2023

Immune checkpoint inhibitors (ICIs) are approved for treatment of small cell lung cancer (SCLC). However, according to ...

Rebecca AraujoNon-Small Cell Lung Cancer | September 21, 2023

Adoptive cell therapy in combination with checkpoint inhibitors may be promising new treatment for patients with ...

Kerri FitzgeraldNon-Small Cell Lung Cancer | September 20, 2023

A phase I/Ib study published in Clinical Cancer Research found that treatment with the immune checkpoint inhibitor ...